Mosaic Company

Mosaic is a producer and marketer of concentrated phosphate and potash crop nutrients. The company is organized into three reportable business segments: Phosphates, which owns and operates mines and production facilities in Florida that produce concentrated phosphate crop nutrients and phosphate-based animal feed ingredients, and processing plants in Louisiana that produce concentrated phosphate crop nutrients; Potash, which mines and processes potash in Canada and the United States and sells potash in North America and internationally; and Mosaic Fertilizantes, which produces and sells concentrated phosphates crop nutrients, phosphate-based animal feed ingredients and potash fertilizer.
  • TickerMOS
  • ISINUS61945C1036
  • ExchangeNew York Stock Exchange
  • SectorChemicals
  • CountryUnited States

MOSAIC suffers a double requalification, which weighs heavily on its rating, now at Slightly Negative.

The independent financial analyst theScreener just downgraded the general evaluation of MOSAIC (US), active in the Speciality Chemicals industry. As regards its fundamental valuation, the title loses a star(s) and now shows 3 out of 4 stars. Its market behaviour is also negatively reassessed and may be considered as risky. theScreener believes that this double requalification keeps the title under pressure and justifies an overall rating downgrade to Slightly Negative. As of the analysis date February 19, 2021, the closing price was USD 29.08 and its target price was estimated at USD 18.31.

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Dave Nicoski ...
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

More Room To Run; Downgrading Utilities Ongoing bullish market dynamics and an absence of breakdowns for major indexes and Sectors continue to support our bullish outlook. As we explain below, new risk-on signals coming from emerging market equities, commodities, and Treasuries continue to be of the bullish variety. We believe this suggests equities have plenty of room to run higher; buy dips. · S&P 500, Nasdaq 100, Russell 2000. Key support levels we are watching on the S&P 500 include short-term support at 3770, with the next important support levels coming in at the uptrend (~3730...

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Dave Nicoski ...
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

Bullish Outlook Intact; Growth vs. Value Stalemate Continues Market dynamics remain positive and there continues to be an absence of breakdowns across the broad indexes and Sectors. As a result we remain bullish and we view any weakness as a buying opportunity. · S&P 500. The S&P 500 is currently testing short-term support in the 3630-3645 zone, which happens to coincide with a multi-week uptrend. If this area fails to hold, the next important support levels to watch would be 3588 followed by 3550. As long as 3550 holds, we believe a bullish intermediate-term outlook is appropriate.....

Dave Nicoski ...
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

Dave Nicoski ...
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

Dave Nicoski ...
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • The U.S. dollar has been unable to break to new highs and is vulnerable. We continue to believe that emerging markets and materials, especially gold are likely to benefit from a weakening U.S. dollar. This market resembles late 2015-early 2016 emerging market rout. • High yield corporate bonds are showing some stabilization as 10-year treasury yields moved to another low in face of the Fed tightening. • A number of Biotechs are indicating reversals and hitting multi-month RS highs.

Dave Nicoski ...
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

It took a couple of days following the Treasury yield breakout for the market to really react, and what we got was a full-blown derailment, as the 6+ month S&P 500 uptrend broke down. With numerous major indexes testing support last week, we highlighted that while we expect to see indexes firm up based on YTD trends, the potential for breakdowns was not far off. In today's report we assess the damage and highlight key support levels. • Key levels to monitor on major indexes. Though the S&P 500, Dow Jones Industrials (DJI), and Nasdaq 100 are all flirting with their respective 200-day moving...

Mosaic Co: 2 directors bought/maiden bought

Two Directors at Mosaic Co bought/maiden bought 15,000 shares at between 9.426USD and 9.956USD. The significance rating of the trade was 73/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under list...

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Dave Nicoski ...
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

More Room To Run; Downgrading Utilities Ongoing bullish market dynamics and an absence of breakdowns for major indexes and Sectors continue to support our bullish outlook. As we explain below, new risk-on signals coming from emerging market equities, commodities, and Treasuries continue to be of the bullish variety. We believe this suggests equities have plenty of room to run higher; buy dips. · S&P 500, Nasdaq 100, Russell 2000. Key support levels we are watching on the S&P 500 include short-term support at 3770, with the next important support levels coming in at the uptrend (~3730...

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Dave Nicoski ...
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

Bullish Outlook Intact; Growth vs. Value Stalemate Continues Market dynamics remain positive and there continues to be an absence of breakdowns across the broad indexes and Sectors. As a result we remain bullish and we view any weakness as a buying opportunity. · S&P 500. The S&P 500 is currently testing short-term support in the 3630-3645 zone, which happens to coincide with a multi-week uptrend. If this area fails to hold, the next important support levels to watch would be 3588 followed by 3550. As long as 3550 holds, we believe a bullish intermediate-term outlook is appropriate.....

Dave Nicoski ...
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

Bullish Outlook Intact Our outlook remains bullish as market dynamics continue to suggest the path of least resistance remains higher for US and foreign equities. Continue to buy dips. · S&P 500. The S&P 500 continues to consolidate/back-and-fill, something we suggested in our 11/10/20 Compass as likely to happen following the ~9% gains in the week surrounding the election which resulted in a bullish reversal. We view recent consolidation following the bullish reversal as healthy as the market collects itself before a likely upside continuation. Short-term support we are watching is ...

Mosaic Company (The): Key Facts and Statistics - LTM June 2020

A summary company profile, detailing Mosaic Company (The)’s business operations and financial highlights.

Moody's announces completion of a periodic review of ratings of Mosaic Company (The)

Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Mosaic Company. Global Credit Research- 07 Oct 2020. New York, October 07, 2020-- Moody's Investors Service has completed a periodic review of the ratings of Mosaic Company and other ratings that are associated with the same analytical unit.

Mosaic Company (The): Update following outlook change to negative

Our credit view of The Mosaic Company highlighting its strong position in phosphate and potash fertilizers but weak credit metrics and uncertainty about phosphate price recovery.

Moody's affirms Mosaic's Baa3 senior unsecured rating, revises outlook to negative

Rating Action: Moody's affirms Mosaic's Baa3 senior unsecured rating, revises outlook to negative. Global Credit Research- 18 Mar 2020. New York, March 18, 2020-- Moody's Investors Service, affirmed the Baa3 senior unsecured ratings of The Mosaic Company and revised the outlook to negative.

Moody's announces completion of a periodic review of ratings of Mosaic Company (The)

Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Mosaic Company. Global Credit Research- 12 Nov 2019. New York, November 12, 2019-- Moody's Investors Service has completed a periodic review of the ratings of Mosaic Company and other ratings that are associated with the same analytical unit.

MOSAIC suffers a double requalification, which weighs heavily on its rating, now at Slightly Negative.

The independent financial analyst theScreener just downgraded the general evaluation of MOSAIC (US), active in the Speciality Chemicals industry. As regards its fundamental valuation, the title loses a star(s) and now shows 3 out of 4 stars. Its market behaviour is also negatively reassessed and may be considered as risky. theScreener believes that this double requalification keeps the title under pressure and justifies an overall rating downgrade to Slightly Negative. As of the analysis date February 19, 2021, the closing price was USD 29.08 and its target price was estimated at USD 18.31.

Ford Equity US Rating and Forecast Report

Ford Equity Research covers more than 4,000 stocks using a proprietary quantitative model that evaluates a company’s earnings strength, its relative valuation and recent price movement. Ford’s five recommendation ratings include strong buy, buy, hold, sell, strong sell. For all stocks in our coverage universe, ratings are generated each week and reflect the fundamental and price data as of the last trading day of the week.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch